other material
confidence high
sentiment neutral
materiality 0.50
CalciMedica files prospectus supplement for up to $25M at-the-market stock offering
CalciMedica, Inc.
- Prospectus supplement covers sale of up to $25,000,000 of CalciMedica common stock under its at-the-market offering agreement with H.C. Wainwright & Co. dated August 11, 2023.
- The ATM sales sit under the company's shelf registration statement on Form S-3 (No. 333-293972), initially filed March 3, 2026 and declared effective March 11, 2026.
- Cooley LLP legal opinion (Exhibit 5.1) covers the legality of the $25,000,000 of shares issuable under the Offering Agreement.
- No pricing, share count, timing schedule, or use-of-proceeds detail was disclosed; shares may be sold from time to time at market prices.